Cancer Currents: An NCI Cancer Research Blog

A blog featuring news and research updates from the National Cancer Institute.

An illustrated banner to represent NCI's Cancer Currents research news blog. The design features interconnected scenes: a patient receiving care, a researcher in a lab, a tumor model, a laptop and mobile device displaying research articles, fitness activity, a clinical setting, and a researcher giving a scientific presentation. The background showcases rolling hills and abstract buildings.

NCI-DOE Collaboration Paving Way for Large-Scale Computational Cancer Science
- By Warren Kibbe, Ph.D.
- February 17, 2016
NCI and the Department of Energy have entered into a collaboration to develop a plan to use large-scale computing to influence cancer science and, ultimately, clinical treatment.
Prospective Study Links HPV Detection in the Mouth to Head and Neck Cancer
- By NCI Staff
- February 12, 2016
A new study confirms that infection with HPV 16 precedes the development of head and neck cancer.
FDA Approves Eribulin Mesylate for Advanced Liposarcoma
- By NCI Staff
- February 11, 2016
The FDA has approved eribulin mesylate for patients with liposarcoma whose cancers are advanced or cannot be removed by surgery and are no longer responding to anthracycline-based chemotherapy.
President Obama’s Budget Request Affirms Commitment to Progress against Cancer
- By Douglas R. Lowy, M.D.
- February 10, 2016
President Obama’s FY 2017 Budget Request includes $680 million to support Vice President Biden’s cancer research initiative.
Mouse Study Points to Mechanism Linking Obesity and Colorectal Cancer Risk
- By NCI Staff
- February 8, 2016
A missing hormone in obese mice may help explain a longstanding association between obesity and an increased risk of colorectal cancer in humans.
Persistent Peripheral Neuropathy Increases Fall Risk among Cancer Survivors
- By NCI Staff
- February 5, 2016
Many female cancer survivors have problems with mobility and other physical functioning as a result of persistent peripheral neuropathy caused by chemotherapy treatment, according to a new study.
Tackling the Global Cancer Burden: A Conversation with NCI’s Dr. Ted Trimble
- By NCI Staff
- February 4, 2016
In honor of World Cancer Day, the director of NCI’s Center for Global Health discusses key opportunities in global cancer research.
The ‘Crisis’ of Low HPV Vaccination Rates: A Conversation with Dr. Noel Brewer
- By NCI Staff
- February 2, 2016
Following the release of a consensus statement from the NCI-Designated Cancer Centers urging HPV vaccination in the United States, Dr. Noel Brewer discusses the country’s low vaccination rates and how clinicians can help to improve them.
NCI-MATCH: A Status Report and Future Directions
- By Barbara Conley, M.D.
- February 1, 2016
Leaders of the NCI-MATCH trial provide an update to the cancer community on the trial’s status and plans for it moving forward.
Opportunities in Cancer Nanotechnology: A Conversation with NCI’s Dr. Piotr Grodzinski
- By NCI Staff
- January 29, 2016
The director of NCI's Office of Cancer Nanotechnology Research discusses the Cancer Nanotechnology Plan 2015, as well as new developments and clinical opportunities in the field.